Jump to content

Bureau of Narcotics and Dangerous Drugs

From Wikipedia, the free encyclopedia
The Bureau of Narcotic and Dangerous Drugs directly preceded the Drug Enforcement Administration.

The Bureau of Narcotics and Dangerous Drugs (BNDD) was a bureau within the United States Department of Justice (DOJ) and a predecessor agency of the modern Drug Enforcement Administration (DEA).

History

[edit]

It was created by § 3 of the Reorganization Plan No. 1 of 1968, submitted to Congress on 7 February 1968 and effective 8 April 1968.[1] It was formed as a subsidiary of the United States Department of Justice, combining the Bureau of Narcotics (from the United States Department of the Treasury) and Bureau of Drug Abuse Control (from the United States Department of Health, Education, and Welfare's Food and Drug Administration) into one agency.

In 1973, the BNDD was merged into the newly formed Drug Enforcement Administration (DEA).

Activities

[edit]

In 1971, the BNDD was composed of 1,500 agents and had a budget of some $43 million (which was more than fourteen times the size of the budget of the former Bureau of Narcotics).[2]

In January 1971 the Central Intelligence Agency (CIA) director, Richard Helms, approved a program of "covert recruitment and security clearance support to BNDD", on request of the BNDD director, John Ingersoll.[3][4] Ingersoll suspected widespread corruption among BNDD agents, and in December 1970 requested the CIA's assistance in rooting it out.[5]

Signs and symptoms

[edit]

Source:[6]

  • having strong cravings for the substance that keep you from thinking about anything else and making you feel as though you have to use it frequently—
  • daily or perhaps multiple times a day
  • gradually requiring more medication to achieve the same result
  • taking the medication for longer than you had meant to and in bigger doses
  • ensuring that you keep the medication on hand
  • spending money on drugs despite not being able to afford them
  • Cutting back on social or recreational activities or failing to fulfill commitments and work responsibilities due to drug usage
  • staying on the medication despite knowing that it’s negatively impacting your life and your health or mental state
  • stealing or engaging in other actions you wouldn’t ordinarily perform in order to obtain the substance
  • Operating a vehicle or engaging in other hazardous tasks while under the influence of drugs
  • Investing a significant amount of time obtaining the drug, taking it, or recuperating from its consequences
  • Not being successful in quitting the drug
  • Having withdrawal symptoms when you try to cut back on the medication

See also

[edit]

References

[edit]
  1. ^ 33 FR 5611, 82 Stat. 1367 at 1368
  2. ^ "The Narcotics Business:John Ingersoll's Version". www.druglibrary.org. Retrieved 2024-05-16.
  3. ^ "CIA's "Family Jewels" - Part 1" (PDF). Central Intelligence Agency (National Security Archive). p. 29. Retrieved 2008-06-16.
  4. ^ "DEA History Book 1970 - 1975". Drug Enforcement Administration. Archived from the original on 2008-02-23. Retrieved 2008-06-16. John E. Ingersoll served as Director of the U.S. Bureau of Narcotics and Dangerous Drugs (BNDD) from 1968 until 1973.
  5. ^ "CIA's "Family Jewels" - Part 1" (PDF). Central Intelligence Agency (National Security Archive). p. 62. Retrieved 2008-06-16.
  6. ^ Zeb, Shanzy (2024-05-16). "What is the most addictive drug - Psychiatry Magazine". Retrieved 2024-06-11.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bureau_of_Narcotics_and_Dangerous_Drugs&oldid=1232673808"